nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—Choline—SLC22A4—Crohn's disease	0.048	0.571	CrCbGaD
Carbachol—Choline—SLC22A5—Crohn's disease	0.0361	0.429	CrCbGaD
Carbachol—PLA2G4A—Dexamethasone—Prednisone—Crohn's disease	0.0131	0.5	CbGdCrCtD
Carbachol—PLA2G4A—Betamethasone—Prednisone—Crohn's disease	0.0131	0.5	CbGdCrCtD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00245	0.0028	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00245	0.00279	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00242	0.00277	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00238	0.00272	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00223	0.00254	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—CCR6—Crohn's disease	0.00217	0.00248	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—JAK2—Crohn's disease	0.00214	0.00244	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00204	0.00233	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00203	0.00232	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.00202	0.00231	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00201	0.0023	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00201	0.0023	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CCR9—Crohn's disease	0.002	0.00229	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CCR9—Crohn's disease	0.00198	0.00227	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00192	0.00219	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00191	0.00218	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00187	0.00213	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—GPR65—Crohn's disease	0.00186	0.00213	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	0.00184	0.00211	CbGpPWpGaD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0018	0.00205	CbGpPWpGaD
Carbachol—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00179	0.00205	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00178	0.00203	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00177	0.00203	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00175	0.002	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00174	0.00199	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00173	0.00197	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CCR9—Crohn's disease	0.00172	0.00196	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00171	0.00196	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00171	0.00195	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—MLN—Crohn's disease	0.00164	0.00187	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—MLN—Crohn's disease	0.00163	0.00187	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	0.00162	0.00185	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PLA2G4F—Crohn's disease	0.0016	0.00183	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—GPR65—Crohn's disease	0.0016	0.00182	CbGpPWpGaD
Carbachol—PLA2G4A—PDGFR-beta signaling pathway—STAT3—Crohn's disease	0.00157	0.00179	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00157	0.00179	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—ACKR2—Crohn's disease	0.00157	0.00179	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	0.00155	0.00177	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ACKR2—Crohn's disease	0.00154	0.00176	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00154	0.00176	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00153	0.00175	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—ITGA4—Crohn's disease	0.00152	0.00174	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00152	0.00174	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MLN—Crohn's disease	0.00149	0.0017	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IL3—Crohn's disease	0.00149	0.0017	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MLN—Crohn's disease	0.00148	0.00169	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MLN—Crohn's disease	0.00147	0.00168	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MLN—Crohn's disease	0.00146	0.00167	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.00146	0.00167	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—RASGRP1—Crohn's disease	0.00144	0.00164	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.00144	0.00164	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—MTMR3—Crohn's disease	0.00136	0.00155	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.00136	0.00155	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TAGAP—Crohn's disease	0.00134	0.00153	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00133	0.00152	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.00133	0.00152	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	0.00131	0.0015	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00117	0.00134	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RSPO3—Crohn's disease	0.00117	0.00134	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.00117	0.00133	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.00116	0.00132	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CCR6—Crohn's disease	0.00114	0.0013	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00114	0.0013	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.00113	0.00129	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.00112	0.00128	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SEL1L—Crohn's disease	0.00111	0.00127	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—FADS1—Crohn's disease	0.00106	0.00121	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00106	0.00121	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.00105	0.0012	CbGpPWpGaD
Carbachol—Ulcer—Mercaptopurine—Crohn's disease	0.00105	0.0756	CcSEcCtD
Carbachol—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.00104	0.00119	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—IL2RA—Crohn's disease	0.00104	0.00119	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00103	0.00118	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.00103	0.00117	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.00102	0.00116	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCR9—Crohn's disease	0.00101	0.00116	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PTGER4—Crohn's disease	0.001	0.00114	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GPX4—Crohn's disease	0.000993	0.00113	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000971	0.00111	CbGpPWpGaD
Carbachol—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000969	0.00111	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000959	0.0011	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GCKR—Crohn's disease	0.000959	0.00109	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.000959	0.00109	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000956	0.00109	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000947	0.00108	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—GPR65—Crohn's disease	0.000943	0.00108	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000931	0.00106	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000927	0.00106	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000925	0.00106	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000916	0.00105	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.000879	0.001	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000876	0.001	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000874	0.000998	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000871	0.000995	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000868	0.000991	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL3—Crohn's disease	0.000853	0.000974	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000834	0.000952	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000831	0.000949	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000825	0.000942	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MTMR3—Crohn's disease	0.000815	0.000931	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000804	0.000918	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000802	0.000915	CbGpPWpGaD
Carbachol—Abdominal cramps—Mesalazine—Crohn's disease	0.000795	0.0575	CcSEcCtD
Carbachol—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000794	0.000906	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000753	0.000859	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—ALB—Crohn's disease	0.000753	0.000859	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.00075	0.000856	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.000743	0.000848	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000703	0.000803	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000701	0.0008	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.0007	0.000799	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—JAK2—Crohn's disease	0.0007	0.000799	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.000694	0.000792	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000685	0.000782	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000683	0.00078	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000681	0.000778	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000676	0.000772	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000675	0.00077	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCR6—Crohn's disease	0.000672	0.000767	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000666	0.000761	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000664	0.000758	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000663	0.000756	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00066	0.000754	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000658	0.000751	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000654	0.000747	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—FADS1—Crohn's disease	0.000635	0.000725	CbGpPWpGaD
Carbachol—Tenderness—Mesalazine—Crohn's disease	0.000615	0.0445	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000609	0.000696	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RBX1—Crohn's disease	0.000607	0.000694	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000607	0.000694	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000602	0.000687	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.000602	0.000687	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.0006	0.000685	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000599	0.000684	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL2RA—Crohn's disease	0.000597	0.000682	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPX4—Crohn's disease	0.000595	0.000679	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000594	0.000678	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTGER4—Crohn's disease	0.000591	0.000675	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GCKR—Crohn's disease	0.000574	0.000656	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000567	0.000647	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000565	0.000645	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000564	0.000644	CbGpPWpGaD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000564	0.000643	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000563	0.000642	CbGpPWpGaD
Carbachol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000562	0.000641	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000559	0.000639	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000557	0.000636	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000556	0.000635	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000546	0.000623	CbGpPWpGaD
Carbachol—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000545	0.000623	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000544	0.000621	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000539	0.000615	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—UBE2D1—Crohn's disease	0.000533	0.000608	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RIPK2—Crohn's disease	0.000517	0.00059	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000512	0.000585	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.000511	0.000583	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000506	0.000578	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL3—Crohn's disease	0.000504	0.000575	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000496	0.000566	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000494	0.000564	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000489	0.000559	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RASGRP1—Crohn's disease	0.000487	0.000556	CbGpPWpGaD
Carbachol—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.000451	0.000515	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SOCS1—Crohn's disease	0.000441	0.000504	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000429	0.00049	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000428	0.000488	CbGpPWpGaD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000427	0.000488	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000426	0.000487	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000424	0.000484	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—TYK2—Crohn's disease	0.000421	0.000481	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000404	0.000461	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000402	0.000459	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—JAK2—Crohn's disease	0.000401	0.000458	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000399	0.000455	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000395	0.000451	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000394	0.00045	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.00039	0.000446	CbGpPWpGaD
Carbachol—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00039	0.0282	CcSEcCtD
Carbachol—PLA2G4A—Signaling Pathways—SMAD3—Crohn's disease	0.000381	0.000435	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CXCL8—Crohn's disease	0.000366	0.000418	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000365	0.000417	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000364	0.000416	CbGpPWpGaD
Carbachol—Necrosis—Prednisone—Crohn's disease	0.000362	0.0262	CcSEcCtD
Carbachol—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.00036	0.000411	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000359	0.00041	CbGpPWpGaD
Carbachol—Abscess—Prednisone—Crohn's disease	0.000359	0.026	CcSEcCtD
Carbachol—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000358	0.000409	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000355	0.000406	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000354	0.000405	CbGpPWpGaD
Carbachol—Abdominal discomfort—Azathioprine—Crohn's disease	0.000354	0.0256	CcSEcCtD
Carbachol—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000354	0.000405	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2RA—Crohn's disease	0.000353	0.000403	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000351	0.000401	CbGpPWpGaD
Carbachol—Cramp muscle—Mesalazine—Crohn's disease	0.000351	0.0254	CcSEcCtD
Carbachol—Asthma—Mesalazine—Crohn's disease	0.000337	0.0244	CcSEcCtD
Carbachol—Abdominal discomfort—Mesalazine—Crohn's disease	0.000323	0.0234	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.00032	0.000366	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000319	0.000364	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000316	0.000361	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.00031	0.000354	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000309	0.000353	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000306	0.00035	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ALB—Crohn's disease	0.000305	0.000348	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000303	0.000346	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000302	0.000345	CbGpPWpGaD
Carbachol—Ulcer—Prednisone—Crohn's disease	0.0003	0.0217	CcSEcCtD
Carbachol—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000299	0.000341	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000293	0.000334	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000292	0.000333	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000289	0.00033	CbGpPWpGaD
Carbachol—Sweating—Mesalazine—Crohn's disease	0.000288	0.0208	CcSEcCtD
Carbachol—Body temperature increased—Mercaptopurine—Crohn's disease	0.000279	0.0202	CcSEcCtD
Carbachol—PLA2G4A—Metabolism—PTGS2—Crohn's disease	0.000267	0.000305	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000266	0.000303	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000265	0.000303	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.000265	0.000302	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000264	0.000302	CbGpPWpGaD
Carbachol—Arrhythmia—Azathioprine—Crohn's disease	0.000264	0.0191	CcSEcCtD
Carbachol—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000262	0.000299	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000262	0.000299	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000253	0.000289	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000252	0.000288	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.00025	0.000285	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TYK2—Crohn's disease	0.000249	0.000284	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000243	0.000277	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000242	0.000276	CbGpPWpGaD
Carbachol—Diarrhoea—Mercaptopurine—Crohn's disease	0.000241	0.0175	CcSEcCtD
Carbachol—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000241	0.000275	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.000241	0.000275	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000239	0.000273	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000238	0.000272	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JAK2—Crohn's disease	0.000237	0.000271	CbGpPWpGaD
Carbachol—Flatulence—Mesalazine—Crohn's disease	0.000231	0.0167	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000229	0.000261	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000228	0.000261	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.000226	0.000258	CbGpPWpGaD
Carbachol—Muscle spasms—Mesalazine—Crohn's disease	0.000226	0.0163	CcSEcCtD
Carbachol—Vomiting—Mercaptopurine—Crohn's disease	0.000224	0.0162	CcSEcCtD
Carbachol—Rash—Mercaptopurine—Crohn's disease	0.000222	0.0161	CcSEcCtD
Carbachol—Dermatitis—Mercaptopurine—Crohn's disease	0.000222	0.0161	CcSEcCtD
Carbachol—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.00022	0.000251	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.00022	0.000251	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000217	0.000248	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CXCL8—Crohn's disease	0.000216	0.000247	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000212	0.000242	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000211	0.000241	CbGpPWpGaD
Carbachol—Syncope—Mesalazine—Crohn's disease	0.00021	0.0152	CcSEcCtD
Carbachol—Nausea—Mercaptopurine—Crohn's disease	0.00021	0.0152	CcSEcCtD
Carbachol—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000209	0.000239	CbGpPWpGaD
Carbachol—Infection—Azathioprine—Crohn's disease	0.000209	0.0151	CcSEcCtD
Carbachol—Loss of consciousness—Mesalazine—Crohn's disease	0.000206	0.0149	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000206	0.0149	CcSEcCtD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—Crohn's disease	0.000206	0.000235	CbGpPWpGaD
Carbachol—Hypotension—Azathioprine—Crohn's disease	0.000196	0.0142	CcSEcCtD
Carbachol—Infection—Mesalazine—Crohn's disease	0.00019	0.0138	CcSEcCtD
Carbachol—Shock—Mesalazine—Crohn's disease	0.000188	0.0136	CcSEcCtD
Carbachol—Hyperhidrosis—Mesalazine—Crohn's disease	0.000185	0.0134	CcSEcCtD
Carbachol—CHRM3—Metabolism—ALB—Crohn's disease	0.000183	0.000209	CbGpPWpGaD
Carbachol—Hypotension—Mesalazine—Crohn's disease	0.000179	0.0129	CcSEcCtD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—Crohn's disease	0.000174	0.000199	CbGpPWpGaD
Carbachol—Sweating increased—Prednisone—Crohn's disease	0.000174	0.0126	CcSEcCtD
Carbachol—Dyspepsia—Mesalazine—Crohn's disease	0.000169	0.0122	CcSEcCtD
Carbachol—Body temperature increased—Azathioprine—Crohn's disease	0.000166	0.012	CcSEcCtD
Carbachol—Abdominal pain—Azathioprine—Crohn's disease	0.000166	0.012	CcSEcCtD
Carbachol—Pain—Mesalazine—Crohn's disease	0.000164	0.0118	CcSEcCtD
Carbachol—CHRM3—Metabolism—PTGS2—Crohn's disease	0.00016	0.000183	CbGpPWpGaD
Carbachol—Abdominal pain—Mesalazine—Crohn's disease	0.000151	0.0109	CcSEcCtD
Carbachol—Body temperature increased—Mesalazine—Crohn's disease	0.000151	0.0109	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—TYK2—Crohn's disease	0.000149	0.000171	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TYK2—Crohn's disease	0.000149	0.00017	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TYK2—Crohn's disease	0.000147	0.000168	CbGpPWpGaD
Carbachol—Diarrhoea—Azathioprine—Crohn's disease	0.000144	0.0104	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—JAK2—Crohn's disease	0.000143	0.000163	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JAK2—Crohn's disease	0.000142	0.000162	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JAK2—Crohn's disease	0.000141	0.000161	CbGpPWpGaD
Carbachol—Dizziness—Azathioprine—Crohn's disease	0.000139	0.0101	CcSEcCtD
Carbachol—Vomiting—Azathioprine—Crohn's disease	0.000134	0.00967	CcSEcCtD
Carbachol—Rash—Azathioprine—Crohn's disease	0.000133	0.00959	CcSEcCtD
Carbachol—Dermatitis—Azathioprine—Crohn's disease	0.000132	0.00958	CcSEcCtD
Carbachol—Flushing—Prednisone—Crohn's disease	0.000132	0.00957	CcSEcCtD
Carbachol—Headache—Azathioprine—Crohn's disease	0.000132	0.00953	CcSEcCtD
Carbachol—Diarrhoea—Mesalazine—Crohn's disease	0.000131	0.00948	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	0.00013	0.000149	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	0.00013	0.000148	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	0.000128	0.000147	CbGpPWpGaD
Carbachol—Arrhythmia—Prednisone—Crohn's disease	0.000127	0.00921	CcSEcCtD
Carbachol—Dizziness—Mesalazine—Crohn's disease	0.000127	0.00916	CcSEcCtD
Carbachol—Nausea—Azathioprine—Crohn's disease	0.000125	0.00903	CcSEcCtD
Carbachol—CHRM1—Signaling by GPCR—IL6—Crohn's disease	0.000124	0.000141	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—Crohn's disease	0.000123	0.000141	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—Crohn's disease	0.000122	0.000139	CbGpPWpGaD
Carbachol—Vomiting—Mesalazine—Crohn's disease	0.000122	0.00881	CcSEcCtD
Carbachol—PLA2G4A—Signaling Pathways—IL6—Crohn's disease	0.000122	0.000139	CbGpPWpGaD
Carbachol—Rash—Mesalazine—Crohn's disease	0.000121	0.00873	CcSEcCtD
Carbachol—Dermatitis—Mesalazine—Crohn's disease	0.000121	0.00873	CcSEcCtD
Carbachol—Headache—Mesalazine—Crohn's disease	0.00012	0.00868	CcSEcCtD
Carbachol—Nausea—Mesalazine—Crohn's disease	0.000114	0.00823	CcSEcCtD
Carbachol—Syncope—Prednisone—Crohn's disease	0.000111	0.00805	CcSEcCtD
Carbachol—Loss of consciousness—Prednisone—Crohn's disease	0.000109	0.00789	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—STAT3—Crohn's disease	0.000105	0.000119	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—Crohn's disease	0.000104	0.000119	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—Crohn's disease	0.000103	0.000118	CbGpPWpGaD
Carbachol—Infection—Prednisone—Crohn's disease	0.000101	0.00728	CcSEcCtD
Carbachol—Shock—Prednisone—Crohn's disease	9.97e-05	0.00721	CcSEcCtD
Carbachol—Hyperhidrosis—Prednisone—Crohn's disease	9.79e-05	0.00708	CcSEcCtD
Carbachol—Dyspepsia—Prednisone—Crohn's disease	8.92e-05	0.00645	CcSEcCtD
Carbachol—Body temperature increased—Prednisone—Crohn's disease	8.01e-05	0.00579	CcSEcCtD
Carbachol—Abdominal pain—Prednisone—Crohn's disease	8.01e-05	0.00579	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—IL6—Crohn's disease	7.31e-05	8.34e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—Crohn's disease	7.28e-05	8.32e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—Crohn's disease	7.21e-05	8.24e-05	CbGpPWpGaD
Carbachol—Diarrhoea—Prednisone—Crohn's disease	6.93e-05	0.00501	CcSEcCtD
Carbachol—Dizziness—Prednisone—Crohn's disease	6.7e-05	0.00485	CcSEcCtD
Carbachol—Vomiting—Prednisone—Crohn's disease	6.44e-05	0.00466	CcSEcCtD
Carbachol—Rash—Prednisone—Crohn's disease	6.39e-05	0.00462	CcSEcCtD
Carbachol—Dermatitis—Prednisone—Crohn's disease	6.38e-05	0.00462	CcSEcCtD
Carbachol—Headache—Prednisone—Crohn's disease	6.35e-05	0.00459	CcSEcCtD
Carbachol—Nausea—Prednisone—Crohn's disease	6.02e-05	0.00435	CcSEcCtD
